Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children
Identifieur interne : 001E65 ( Main/Exploration ); précédent : 001E64; suivant : 001E66Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children
Auteurs : Pedro A. Piedra [États-Unis] ; W. Paul Glezen [États-Unis] ; Innocent Mbawuike [États-Unis] ; William C. Gruber [États-Unis] ; Barbara D. Baxter [États-Unis] ; F. James Boland [États-Unis] ; Richard W. Byrd [États-Unis] ; Lawrence L. Fan [États-Unis] ; Jessica K. Lewis [États-Unis] ; Linda J. Rhodes [États-Unis] ; Stephen E. Whitney [États-Unis] ; Larry H. Taber [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 1993.
English descriptors
- Teeft :
- Attenuated, Bivalent, Cidso, Glezen, Greater rise, Immune response, Immunogenicity, Infant, Infection, Influenza, Influenza epidemic, Influenza epidemics, Influenza season, Influenza type, Influenza vaccine, Influenza vaccines, Influenza virus, Influenza viruses, Intercurrent, Nasal, Neutralizing, Neutralizing antibody, Otitis media, Physical examination, Piedra, Placebo, Placebo group, Postimmunization, Postvaccination, Reactogenicity, Recombinant, Respiratory illness, Respiratory illnesses, Seronegative, Seronegative children, Significant rise, Standard deviation, Sterile saline, Study year, Study years, Trivalent, Vaccination, Vaccine, Vaccinee, Viral, Viral infection, Virus, Virus vaccines, Young children.
Abstract
Abstract: Fifty-two infants seronegative to or without prior infection with influenza type A viruses were enrolled in a study to evaluate reactogenicity and immunogenicity of three bivalent cold recombinant type A (CRA) and two trivalent inactivated influenza (TI) vaccines. Controls consisted of infants receiving normal saline by nose drops (Pli.n.) or intramuscularly (Pli.m.). CRA and TI vaccinees were monitored for local and systemic reactions after vaccination. Serum specimens obtained prior to and 6 weeks postvaccination were analysed for neutralizing antibody to influenza H1N1 and H3N2 viruses. CRA vaccinees and Pli.n. recipients had similar numbers of acute respiratory infections and comparable rates of illnesses during the trial. Significantly fewer CRA vaccinees without an intercurrent viral infection had fever (0/16 versus 4/10, p = 0.04) and cough (4/16 versus 9/10, p = 0.002) than CRA vaccinees with a confirmed intercurrent viral infection. Recipients of TI vaccine and Pli.m. did not develop reactions at the injection site. For each of the CRA vaccines tested, a dominant CRA virus was identified. The dominant CRA viruses were isolated from a greater number of infants or for a longer duration than the non-dominant CRA viruses. All 14 non-dominant CRA viruses were recovered from infants within the first week after vaccination; 24 of 77 dominant CRA viruses were recovered more than 7 days after vaccination. The immunogenicity of CRA vaccines was not affected by a confirmed intercurrent viral infection or low titres of influenza-specific antibody. However, interference was observed between the CRA viruses in the bivalent CRA vaccines. Immunogenicity of TI vaccine may have been affected by low titres of influenza-specific antibody.
Url:
DOI: 10.1016/0264-410X(93)90255-V
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001583
- to stream Istex, to step Curation: 001583
- to stream Istex, to step Checkpoint: 000C29
- to stream Main, to step Merge: 001F54
- to stream Main, to step Curation: 001E65
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children</title><author><name sortKey="Piedra, Pedro A" sort="Piedra, Pedro A" uniqKey="Piedra P" first="Pedro A." last="Piedra">Pedro A. Piedra</name></author><author><name sortKey="Glezen, W Paul" sort="Glezen, W Paul" uniqKey="Glezen W" first="W. Paul" last="Glezen">W. Paul Glezen</name></author><author><name sortKey="Mbawuike, Innocent" sort="Mbawuike, Innocent" uniqKey="Mbawuike I" first="Innocent" last="Mbawuike">Innocent Mbawuike</name></author><author><name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name></author><author><name sortKey="Baxter, Barbara D" sort="Baxter, Barbara D" uniqKey="Baxter B" first="Barbara D." last="Baxter">Barbara D. Baxter</name></author><author><name sortKey="Boland, F James" sort="Boland, F James" uniqKey="Boland F" first="F. James" last="Boland">F. James Boland</name></author><author><name sortKey="Byrd, Richard W" sort="Byrd, Richard W" uniqKey="Byrd R" first="Richard W." last="Byrd">Richard W. Byrd</name></author><author><name sortKey="Fan, Lawrence L" sort="Fan, Lawrence L" uniqKey="Fan L" first="Lawrence L." last="Fan">Lawrence L. Fan</name></author><author><name sortKey="Lewis, Jessica K" sort="Lewis, Jessica K" uniqKey="Lewis J" first="Jessica K." last="Lewis">Jessica K. Lewis</name></author><author><name sortKey="Rhodes, Linda J" sort="Rhodes, Linda J" uniqKey="Rhodes L" first="Linda J." last="Rhodes">Linda J. Rhodes</name></author><author><name sortKey="Whitney, Stephen E" sort="Whitney, Stephen E" uniqKey="Whitney S" first="Stephen E." last="Whitney">Stephen E. Whitney</name></author><author><name sortKey="Taber, Larry H" sort="Taber, Larry H" uniqKey="Taber L" first="Larry H." last="Taber">Larry H. Taber</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2B8B2D38B077A27611848AEEEBDC3C7B24DF0650</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1016/0264-410X(93)90255-V</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-GSJPHWZV-Z/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001583</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001583</idno><idno type="wicri:Area/Istex/Curation">001583</idno><idno type="wicri:Area/Istex/Checkpoint">000C29</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C29</idno><idno type="wicri:doubleKey">0264-410X:1993:Piedra P:studies:on:reactogenicity</idno><idno type="wicri:Area/Main/Merge">001F54</idno><idno type="wicri:Area/Main/Curation">001E65</idno><idno type="wicri:Area/Main/Exploration">001E65</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children</title><author><name sortKey="Piedra, Pedro A" sort="Piedra, Pedro A" uniqKey="Piedra P" first="Pedro A." last="Piedra">Pedro A. Piedra</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Baylor College of Medicine, Influenza Research Center, One Baylor Plaza, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Glezen, W Paul" sort="Glezen, W Paul" uniqKey="Glezen W" first="W. Paul" last="Glezen">W. Paul Glezen</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Baylor College of Medicine, Influenza Research Center, One Baylor Plaza, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Mbawuike, Innocent" sort="Mbawuike, Innocent" uniqKey="Mbawuike I" first="Innocent" last="Mbawuike">Innocent Mbawuike</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Baylor College of Medicine, Influenza Research Center, One Baylor Plaza, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Baylor College of Medicine, Influenza Research Center, One Baylor Plaza, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Baxter, Barbara D" sort="Baxter, Barbara D" uniqKey="Baxter B" first="Barbara D." last="Baxter">Barbara D. Baxter</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Baylor College of Medicine, Influenza Research Center, One Baylor Plaza, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Boland, F James" sort="Boland, F James" uniqKey="Boland F" first="F. James" last="Boland">F. James Boland</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Fifth Ward Pediatric Clinic, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Byrd, Richard W" sort="Byrd, Richard W" uniqKey="Byrd R" first="Richard W." last="Byrd">Richard W. Byrd</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Kelsey-Seybold Clinic, P.A., Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Fan, Lawrence L" sort="Fan, Lawrence L" uniqKey="Fan L" first="Lawrence L." last="Fan">Lawrence L. Fan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Kelsey-Seybold Clinic, P.A., Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Lewis, Jessica K" sort="Lewis, Jessica K" uniqKey="Lewis J" first="Jessica K." last="Lewis">Jessica K. Lewis</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Kelsey-Seybold Clinic, P.A., Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Rhodes, Linda J" sort="Rhodes, Linda J" uniqKey="Rhodes L" first="Linda J." last="Rhodes">Linda J. Rhodes</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Kelsey-Seybold Clinic, P.A., Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Whitney, Stephen E" sort="Whitney, Stephen E" uniqKey="Whitney S" first="Stephen E." last="Whitney">Stephen E. Whitney</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Fifth Ward Pediatric Clinic, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Taber, Larry H" sort="Taber, Larry H" uniqKey="Taber L" first="Larry H." last="Taber">Larry H. Taber</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Baylor College of Medicine, Influenza Research Center, One Baylor Plaza, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Vaccine</title><title level="j" type="abbrev">JVAC</title><idno type="ISSN">0264-410X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1993">1993</date><biblScope unit="volume">11</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="718">718</biblScope><biblScope unit="page" to="724">724</biblScope></imprint><idno type="ISSN">0264-410X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0264-410X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Attenuated</term><term>Bivalent</term><term>Cidso</term><term>Glezen</term><term>Greater rise</term><term>Immune response</term><term>Immunogenicity</term><term>Infant</term><term>Infection</term><term>Influenza</term><term>Influenza epidemic</term><term>Influenza epidemics</term><term>Influenza season</term><term>Influenza type</term><term>Influenza vaccine</term><term>Influenza vaccines</term><term>Influenza virus</term><term>Influenza viruses</term><term>Intercurrent</term><term>Nasal</term><term>Neutralizing</term><term>Neutralizing antibody</term><term>Otitis media</term><term>Physical examination</term><term>Piedra</term><term>Placebo</term><term>Placebo group</term><term>Postimmunization</term><term>Postvaccination</term><term>Reactogenicity</term><term>Recombinant</term><term>Respiratory illness</term><term>Respiratory illnesses</term><term>Seronegative</term><term>Seronegative children</term><term>Significant rise</term><term>Standard deviation</term><term>Sterile saline</term><term>Study year</term><term>Study years</term><term>Trivalent</term><term>Vaccination</term><term>Vaccine</term><term>Vaccinee</term><term>Viral</term><term>Viral infection</term><term>Virus</term><term>Virus vaccines</term><term>Young children</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Fifty-two infants seronegative to or without prior infection with influenza type A viruses were enrolled in a study to evaluate reactogenicity and immunogenicity of three bivalent cold recombinant type A (CRA) and two trivalent inactivated influenza (TI) vaccines. Controls consisted of infants receiving normal saline by nose drops (Pli.n.) or intramuscularly (Pli.m.). CRA and TI vaccinees were monitored for local and systemic reactions after vaccination. Serum specimens obtained prior to and 6 weeks postvaccination were analysed for neutralizing antibody to influenza H1N1 and H3N2 viruses. CRA vaccinees and Pli.n. recipients had similar numbers of acute respiratory infections and comparable rates of illnesses during the trial. Significantly fewer CRA vaccinees without an intercurrent viral infection had fever (0/16 versus 4/10, p = 0.04) and cough (4/16 versus 9/10, p = 0.002) than CRA vaccinees with a confirmed intercurrent viral infection. Recipients of TI vaccine and Pli.m. did not develop reactions at the injection site. For each of the CRA vaccines tested, a dominant CRA virus was identified. The dominant CRA viruses were isolated from a greater number of infants or for a longer duration than the non-dominant CRA viruses. All 14 non-dominant CRA viruses were recovered from infants within the first week after vaccination; 24 of 77 dominant CRA viruses were recovered more than 7 days after vaccination. The immunogenicity of CRA vaccines was not affected by a confirmed intercurrent viral infection or low titres of influenza-specific antibody. However, interference was observed between the CRA viruses in the bivalent CRA vaccines. Immunogenicity of TI vaccine may have been affected by low titres of influenza-specific antibody.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Piedra, Pedro A" sort="Piedra, Pedro A" uniqKey="Piedra P" first="Pedro A." last="Piedra">Pedro A. Piedra</name></region><name sortKey="Baxter, Barbara D" sort="Baxter, Barbara D" uniqKey="Baxter B" first="Barbara D." last="Baxter">Barbara D. Baxter</name><name sortKey="Boland, F James" sort="Boland, F James" uniqKey="Boland F" first="F. James" last="Boland">F. James Boland</name><name sortKey="Byrd, Richard W" sort="Byrd, Richard W" uniqKey="Byrd R" first="Richard W." last="Byrd">Richard W. Byrd</name><name sortKey="Fan, Lawrence L" sort="Fan, Lawrence L" uniqKey="Fan L" first="Lawrence L." last="Fan">Lawrence L. Fan</name><name sortKey="Glezen, W Paul" sort="Glezen, W Paul" uniqKey="Glezen W" first="W. Paul" last="Glezen">W. Paul Glezen</name><name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name><name sortKey="Lewis, Jessica K" sort="Lewis, Jessica K" uniqKey="Lewis J" first="Jessica K." last="Lewis">Jessica K. Lewis</name><name sortKey="Mbawuike, Innocent" sort="Mbawuike, Innocent" uniqKey="Mbawuike I" first="Innocent" last="Mbawuike">Innocent Mbawuike</name><name sortKey="Rhodes, Linda J" sort="Rhodes, Linda J" uniqKey="Rhodes L" first="Linda J." last="Rhodes">Linda J. Rhodes</name><name sortKey="Taber, Larry H" sort="Taber, Larry H" uniqKey="Taber L" first="Larry H." last="Taber">Larry H. Taber</name><name sortKey="Whitney, Stephen E" sort="Whitney, Stephen E" uniqKey="Whitney S" first="Stephen E." last="Whitney">Stephen E. Whitney</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E65 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E65 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:2B8B2D38B077A27611848AEEEBDC3C7B24DF0650
|texte= Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children
}}
| This area was generated with Dilib version V0.6.33. |  |